Author and publication year | Reported pharmacological treatment for aHT |
---|---|
Steyn et al. 1993 [62] | •Men: 25.3% ß-blockers, 22.3% diuretics, 6.4% reserpine-containing preparations •Women: 43.2% diuretics, 15% reserpine-containing preparations, 14.6% ß-blockers |
Oparah et al. 2006 [60] | •Prior to intervention: 33% methyldopa, 11% diuretics, 33% combinations •Intervention: JNC (Joint National Committee) VII guidelines*, 2004 |
Ndou et al. 2013 [51] | NR |
Khabala et al. 2015 [58] | NR |
Marfo et al. 2017 [55] | NR |
Nelissen et al. 2018 [61] | NR |
Kuria et al. 2018 [54] | NR |
Adler et al. 2019 [52] | •At enrolment: 36% used a calcium channel blocker (CCB) •After 6-months enrolment: 75.9% patients used diuretics and 69.5% were on a CCB. A total of 24.1% were taking only one medication, 32% were taking two medications and over 30% were taking more than two medications •At 12 m-enrolment: 79.8% were on diuretics, and 71.5% taking a CCB.A total of 23% were taking one medication, 32.6% were taking two medications and over 32% were taking more than two medications |
Bolarinwa et al. 2019 [59] | NR |
Stephens et al. 2021 [53] | NR |
Otieno et al. 2021 [57] | •A total of 74% of patients were on calcium channel blocker, 64% on ACE or ARB and 14% on diuretics. A minority of patients used other treatments |
Vedanthan et al. 2021 [56] | •Use of diuretics if SBP \(\ge\) 140 and < 180 OR DBP \(\ge\) 90 and < 110, without edema of legs or dyspnoea on exertion or reduced urine output •Treatment of hypertension in Diabetes: initial ACE inhibitors. Escalate to ARBs with/without diuretics |